Literature DB >> 15589561

Inflammatory markers in depressed post-myocardial infarction patients.

Annique Schins1, Schins Annique, Dorien Tulner, Tulner Dorien, Richel Lousberg, Lousberg Richel, Gunter Kenis, Kenis Gunter, Joris Delanghe, Delanghe Joris, Harry J Crijns, J Crijns Harry, Gert Grauls, Grauls Gert, Frank Stassen, Stassen Frank, Michael Maes, Maes Michael, Adriaan Honig, Honig Adriaan.   

Abstract

BACKGROUND: Depressive disorder in the post-myocardial infarction (MI) period has been associated with increased cardiac morbidity and mortality. Possible pathophysiological mechanisms behind this association are not clear. Major depression in physically healthy subjects has been related to immune abnormalities including increased plasma levels of interleukin-6 (IL-6), tumor necrosis factor alfa (TNF-alpha) and C-reactive protein (CRP). In patients with MI, increased inflammatory markers, such as CRP and TNF-alpha, have been associated with increased cardiovascular events. It was the aim of this study to test the hypothesis that depression in post-MI patients is associated with increased inflammation as compared to non-depressed post-MI patients.
METHODS: The cytokines IL-6 and TNF-alpha ; the soluble cytokine receptors sIL-6R, sTNF-RI and sTNF-RII; neopterin; and the inflammation-sensitive plasma proteins (ISPs) CRP and haptoglobin were assessed in a group of 57 patients with a diagnosis of depression post-MI and in a control group of 46 non-depressed post-MI patients, matched for age, gender and time elapsed since MI.
RESULTS: Cytokine, neopterin and ISP levels were not statistically different in the depressed post-MI group as compared to the non-depressed post-MI group. Several inflammatory markers were however elevated in both cohorts when compared with levels reported in healthy subjects, indicating persistent inflammation several months after MI.
CONCLUSIONS: There was no indication of increased inflammation in depressed post-MI patients as compared to non-depressed post-MI patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15589561     DOI: 10.1016/j.jpsychires.2004.05.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  17 in total

Review 1.  Depression in people with coronary heart disease: prognostic significance and mechanisms.

Authors:  Chris Dickens
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

2.  Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome.

Authors:  D Shimbo; N Rieckmann; R Paulino; K W Davidson
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

3.  Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Álvaro Camacho; Britta Larsen; Robyn L McClelland; Cindy Morgan; Michael H Criqui; Mary Cushman; Matthew A Allison
Journal:  J Affect Disord       Date:  2014-04-19       Impact factor: 4.839

4.  Inflammation markers in individuals with history of mental health crisis.

Authors:  Dan Justo; Yaron Arbel; Gal Altberg; Michael Kinori; Arie Shirom; Samuel Melamed; Itzhak Shapira; Ori Rogowski
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

Review 5.  Depression and coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

6.  Effects of Gender-Specific Differences, Inflammatory Response, and Genetic Variation on the Associations Among Depressive Symptoms and the Risk of Major Adverse Coronary Events in Patients With Acute Coronary Syndrome.

Authors:  Jennifer Sanner; Megan L Grove; Erica Yu; F Gerard Moeller; Stanley G Cron; Eric Boerwinkle; Alanna C Morrison; Lorraine Frazier
Journal:  Biol Res Nurs       Date:  2018-01-03       Impact factor: 2.522

7.  Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Authors:  Mariska Bot; Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; Douglas L Mann
Journal:  J Psychosom Res       Date:  2011-01-15       Impact factor: 3.006

8.  Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry.

Authors:  Kim G Smolderen; John A Spertus; Kimberly J Reid; Donna M Buchanan; Viola Vaccarino; Judith H Lichtman; David B Bekelman; Paul S Chan
Journal:  Biol Psychiatry       Date:  2011-09-08       Impact factor: 13.382

9.  Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study.

Authors:  Mary A Whooley; Catherine M Caska; Bethany E Hendrickson; Meghan A Rourke; Joseph Ho; Sadia Ali
Journal:  Biol Psychiatry       Date:  2007-04-16       Impact factor: 13.382

10.  Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts.

Authors:  Gregory A Wellenius; Kenneth J Mukamal; Ambar Kulshreshtha; Sharon Asonganyi; Murray A Mittleman
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.